Edition:
United States

People: Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

4.55SEK
18 Aug 2017
Change (% chg)

-0.17kr (-3.60%)
Prev Close
4.72kr
Open
4.70kr
Day's High
4.70kr
Day's Low
4.54kr
Volume
66,365
Avg. Vol
409,875
52-wk High
21.90kr
52-wk Low
4.17kr

Tuvesson, Helen 

Ms. Helen Tuvesson has been appointed Chief Executive Officer at Active Biotech AB effective as of July 1, 2017. She has previously served as Chief Scientific Officer at Active Biotech AB since April 1, 2011. She was previously Head of Preclinical Development at the Company until April 1, 2011. Ms. Tuvesson has been employed at Active Biotech AB since 1998. She has worked in the pharmaceutical industry for almost 20 years and has held various positions at Pharmacia. She is Doctor of Cellular and Molecular Biology from Lunds universitet.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --